Atlas Trials

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.

Clinical trial NCT04558892 · TERMINATED

Trial details

NCT number
NCT04558892
Sponsor
Military Institute od Medicine National Research Institute
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Nephrotic Syndrome
Start date
2015-10-01
Primary completion
2018-11-30
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.